Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 9 ... (2) dysphagia screening; (3) admission to a stroke unit; (4) carotid imaging; (5) antithrombotic therapy; and (6) warfarin for atrial fibrillation at discharge. were risk-adjusted ...
2009 NOV 9 ... colleagues published their study in Clinical and Applied Thrombosis - Hemostasis (Oral Antithrombotic Inhibitors: Dabigatran Etexilate, Meeting an Unmet Need? Clinical and Applied Thrombosis ...
2009 NOV 9 ... (DHG) is a fucosylated chondroitin sulfate with antithrombin-independent antithrombotic properties. Heparin cofactor II (HCII)-dependent and -independent mechanisms for DHG ...
2009 NOV 16 ... inhibitory effects on platelets. This new finding contributes to the understanding of antithrombotic and also anti-inflammatory effects of celastrol." Hu and colleagues ...
2009 NOV 2 ... (ERD) is widely used in patients after ischaemic stroke; however, the ability of this antithrombotic agent to be stored in different blood cells has never been explored in post-stroke ...
2009 NOV 23 ... of a validated clinical bleed risk score, and new patient and physician user-friendly antithrombotic medication may contribute to improved adequate use of oral anticoagulation in AF ...
2009 NOV 23 ... "In three PCI trials, treatment of patients experiencing CA perforation with adjunctive antithrombotic therapy of bivalirudin monotherapy was not associated with worse outcomes compared to ...
2009 NOV 23 ... mediates reverse cholesterol transport, but also exerts antioxidant, anti-inflammatory, antithrombotic and vasodilatory effects. These multiple antiatherosclerotic properties provide an ...
2009 NOV 9 ... activation is in part cyclooxygenase-dependent and suggest that the KAR is a novel antithrombotic target. ( Circ Res. 2009; 105:595-603.)." Sun and colleagues published the ...
2009 NOV 9 ... link between inflammation and thrombosis and suggest it as an attractive target for antithrombotic therapy. (Circulation. 2009;120:1255-1265.)." Hirahashi and colleagues ...
2009 NOV 9 ... According to a study from the United States, "Sulodexide represents a novel antithrombotic agent with Multiple sites of action on blood coagulation and vascular processes. The ...
2009 NOV 9 ... Canada, "Many patients with atrial fibrillation are at high risk for stroke and require antithrombotic therapy. Antiarrhythmic drugs have not previously been shown to reduce the risk of ...
2009 NOV 2 ... on human blood and increases thrombogenesis on damaged vascular surfaces. The remarkable antithrombotic actions achieved through SSRI deserve further mechanistic and clinical investigations." ...
2009 NOV 23 ... Both compounds are able to inhibit SFLLR-induced human platelet aggregation and display antithrombotic activity in an arteriovenous shunt model in the rat after iv or oral administration," ...
2009 NOV 23 ... Hylek and colleagues published their study in Seminars in Thrombosis and Hemostasis (Antithrombotic Prophylaxis in Elderly Patients with Atrial Fibrillation. Seminars in Thrombosis and ...
2009 NOV 10 ... Keywords: Norway, Life Sciences, Tissue Engineering, Lepirudin, Anticoagulant, Antithrombotic, Inflammation. This article was prepared by Science Letter editors from ...
